Skip to main content

Advertisement

Table 2 Summary of reported AIDS-defining illnesses (ADI) by year of HAART initiation

From: Trends in reported AIDS defining illnesses (ADIs) among participants in a universal antiretroviral therapy program: an observational study

ERA (n) 1996-98
(967)
1999-01
(897)
2002-04
(783)
2005-07
(1074)
Total
(3721)
p-value
Any ADI (%) 44
(4.5)
50
(5.6)
61
(7.8)
59
(5.5)
214 (5.75) 0.181
Kaposi's Sarcoma (%) 7 (0.7) 10 (1.1) 13 (1.7) 12 (1.1) 42 (1.1) 0.295
Pnemocystis jirovecii pneumonia (%) 12 (1.2) 8 (0.9) 7 (0.9) 9 (0.8) 36 (0.97) 0.386
Non-Hodgkin's Lymphoma (%) 9 (0.9) 9 (1.0) 6 (0.8) 8 (0.7) 32 (0.86) 0.552
Mycobacterium avium intracellae (%) 6 (0.6) 6 (0.7) 11 (1.4) 5 (0.5) 28 (0.75) 0.971
HIV Wasting Snydrome (%) 3 (0.3) 3 (0.3) 6 (0.8) 8 (0.7) 20 (0.54) 0.103
Mycobacterium Tuberculosis (%) 0 (0) 7 (0.8) 4 (0.5) 4 (0.4) 15 (0.40) 0.363
Cryptococcal Meningitis (%) 3 (0.3) 2 (0.2) 5 (0.6) 3 (0.3) 13 (0.35) 0.785
  1. n = number who initiated HAART in each period